Today
-1.88%
5 Days
-4.27%
1 Month
-47.14%
6 Months
-87.13%
Year to Date
-92.27%
1 Year
-95.36%
Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Revenue Up 35%, Liquidity Risks Persist


| Shareholders | Proportion |
|---|---|
| V-CO Investors, L.L.C. | 9.87% |
| Skaff (Michael C.) | 9.79% |
| Luo (Dawei) | 4.17% |
| Armistice Capital LLC | 1.82% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 14.52% |
| Corporation | 11.54% |
| Investment Advisor | 2.63% |
| Hedge Fund | 1.85% |
Related Instruments